Bio View Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Bio View's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Bio View in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.000.000.00
Details
Intrinsic
Valuation
LowReal ValueHigh
0.000.000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bio View. Your research has to be compared to or analyzed against Bio View's peers to derive any actionable benefits. When done correctly, Bio View's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Bio-View.

Bio View Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bio View and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Bio View and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bio-View does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Bio View Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Bio View Stock performing well and Bio View company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Bio View's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
TWTR 1.73  0.48  0.18  2.46  1.73  0.13 (1.84)  3.56 (2.97)  27.10 
MSFT 1.81 (0.12)  0.00 (0.02)  0.00 (0.0384)  0.00  3.92 (3.54)  11.64 
UBER 2.79 (0.01)  0.01  0.06  3.22  0.0048 (3.38)  8.60 (5.58)  19.67 
F 1.95 (0.20)  0.00 (0.07)  0.00 (0.06)  0.00  2.75 (5.14)  14.93 
T 1.27  0.11  0.06  0.21  1.22  0.05 (1.43)  2.54 (2.11)  9.29 
A 1.71  0.22  0.13  0.24  1.62  0.11 (2.06)  3.98 (2.97)  11.04 
CRM 2.20 (0.06) (0.01)  0.02  2.64 (0.013) (2.24)  4.31 (4.29)  14.31 
JPM 1.49  0.24  0.15  0.29  1.27  0.13 (1.60)  4.20 (2.15)  7.57 
MRK 1.03  0.34  0.23  1.09  0.89  0.22 (1.22)  2.44 (1.71)  7.38 
XOM 1.62  0.12  0.06  0.20  1.90  0.06 (1.68)  3.65 (3.00)  9.75 

Bio View Competitive Analysis

The better you understand Bio View competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bio View's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bio View's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
RSEL
 1.36 
 305.00 
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Return On Asset
Book Value Per Share
Cash and Equivalents
Current Liabilities
Total Asset
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Daily Balance Of Power
Day Typical Price
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Bio View Competition Performance Charts

Complement your Bio View position

In addition to having Bio View in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Insurance Providers Thematic Idea Now

Insurance Providers
Insurance Providers Theme
Companies providing all types of insurance and insurance services. The Insurance Providers theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Providers Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities. You can also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Tools for Bio View Stock

When running Bio-View price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Bio-View competes with RSL Electronics; as well as few others. The company operates under Healthcare sector and is part of Medical Devices industry. Analyzing Bio View competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bio View to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bio View competition on your existing holdings. Check out Trending Equities.